Extramural Research Opportunities

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)

Application Due Date (s): September 29, 2021 (LOI) ; October 29, 2021 (Application)

Sponsoring Agency: National Institutes of Health (NIH) United States Department of Health and Human Services (HHS)

Amount Available: Estimated total of $8M to fund 5 awards per receipt date. The maximum project period is 5 years.

Abstract: Invasive surgical procedures provide the unique ability to record and stimulate neurons within precisely localized brain structures in humans.  Human studies using invasive technology are often constrained by a limited number of patients and resources available to implement complex experimental protocols and are rarely aggregated in a manner that addresses research questions with appropriate statistical power.  Therefore, this RFA seeks applications to assemble diverse, integrated, multi-disciplinary teams that cross boundaries of interdisciplinary collaboration to overcome these fundamental barriers and to investigate high-impact questions in human neuroscience.  Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. Projects should employ approaches guided by specified theoretical constructs and quantitative, mechanistic models where appropriate.

Awardees will join a consortium work group, coordinated by the NIH, to identify consensus standards of practice, including neuroethical considerations, to collect and provide data for ancillary studies, and to aggregate and standardize data for dissemination among the wider scientific community.

Funding Website: 
RFA-NS-19-001 

Keywords: Brain Data Management or Analysis (Medical); Nervous System; Neuroscience; Surgery & Intensive Care

Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)

Application Due Date (s): October 05, 2021, February 05, 2022, June 05, 2022

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years.

Abstract: This Funding Opportunity Announcement (FOA) supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. Applications must use experimental designs that incorporate active manipulations to address at least one, and ideally more, of the following topics: (1) in animals or humans, determine which parameters of neural coordination, when manipulated in isolation, improve particular aspects of cognitive, affective, or social processing; (2) in animals or humans, determine how particular abnormalities at the genomic, molecular, or cellular levels affect the systems-level coordination of electrophysiological patterns during behavior; (3) determine whether in vivo, systems-level electrophysiological changes in behaving animals predict analogous electrophysiological and cognitive improvements in healthy persons or clinical populations; and (4) use biologically-realistic computational models that include systems-level aspects to understand the function and mechanisms by which oscillatory and other electrophysiological patterns unfold across the brain to impact cognitive, affective, or social processing. This FOA uses the R01 grant mechanism, whereas its companion FOA, PAR-21-176, seeks shorter, higher-risk R21 grant applications. Components of Participating Organizations: National Institute of Mental Health (NIMH)

Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit, Small Business only

Funding Website: 
PAR-21-175

Keywords: Animal Models, Brain Disorders, Cognitive Development or Processes, Computational Neuroscience, Computer Modeling, Neural Stimulation, Neurological Disorders, Neurophysiology, Neuropsychiatry

Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)

Application Due Date (s): October 05, 2021, February 05, 2022, June 05, 2022

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years.

Abstract: This Funding Opportunity Announcement (FOA) encourages research to develop task-based behavioral measures that are shown to engage brain systems relevant to anhedonia using neuroimaging or other brain measures with similar spatial resolution. The goal is to identify behavioral tasks that can be used as quantitative tools in future studies of the functional constructs associated with anhedonia and in treatment development. This Funding Opportunity Announcement is for basic science experimental studies involving human participants that fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of brain function in healthy individuals or those with disorders. These mechanistic studies are expected to be responsive to the BESH FOAs https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-006.html since they are not intended to inform on the improvement of the health status of the individual or a group of individuals either by better understanding the mechanism of action of an intervention or a measurable improvement in health.

Funding Website: 
PAR-20-235

Keywords: Animal Models, Brain Disorders, Cognitive Development or Processes, Computational Neuroscience, Computer Modeling, Neural Stimulation, Neurological Disorders, Neurophysiology, Neuropsychiatry

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Application Due Date (s): October 05, 2021, February 05, 2022, June 05, 2022

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available:  The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years

Abstract: The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD. This FOA uses the R01 mechanism, while the companion announcement PAR-20-159 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism.

Funding Website: 
PAR-20-157

Keywords: Alzheimers Disease, Dementia, Neuropsychiatry

BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)

Application Due Date (s):  October 07, 2021 | LOI - due 30 days prior, optional  

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: Up to $300,000 USD. The maximum project period is 3 years.

Abstract: This Funding Opportunity Announcement (FOA) encourages secondary analysis of the large amounts of existing data relevant to the goals of the BRAIN Initiative. The data do not need to be held in one of the funded BRAIN Initiative data archives, but the data must be held in a data archive that is readily accessible to the research community. Support will be provided for innovative analysis of relevant existing datasets using conventional or novel analytic methods, data science techniques, and machine learning approaches. Support may also be requested to prepare and submit existing data into any of the BRAIN Initiative data archives. Investigators should not underestimate the time and effort that may be necessary to curate or harmonize data.

The goal of this FOA is to promote studies that will significantly advance new discoveries and accelerate the pace of research of the BRAIN Initiative through harnessing the big data and machine learning opportunities. Awardees are expected to enhance the value of existing data, improve the overall data integration and analysis capability, and strengthen the statistical power and rigor and reproducibility of BRAIN Initiative related data.

Funding Website: 
RFA-MH-21-130

Keywords: Informatics & Big Data, Machine Learning, Neuroscience

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Application Due Date (s): October 16, 2021, February 16, 2022, or June 16, 2022

Sponsoring Agencies: National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Sponsoring Agencies: Budgets for direct costs of up to $150,000 per year and is for a period of one year only. The maximum project period is 1 year 

Abtract: This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs, to enable the conduct of small "proof of concept" studies. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources.

Funding Website: 
PAR-18-918

Keywords: Neuroimaging, Radiology & Medical Imaging

Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21)

Application Due Date (s): October 16, 2021, February 16, 2022, June 16, 2022

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. 

Abstract: This Funding Opportunity Announcement (FOA) supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. Applications must use experimental designs that incorporate active manipulations to address at least one, and ideally more, of the following topics: (1) in animals or humans, determine which parameters of neural coordination, when manipulated in isolation, improve particular aspects of cognitive, affective, or social processing; (2) in animals or humans, determine how particular abnormalities at the genomic, molecular, or cellular levels affect the systems-level coordination of electrophysiological patterns during behavior; (3) determine whether in vivo, systems-level electrophysiological changes in behaving animals predict analogous electrophysiological and cognitive improvements in healthy persons or clinical populations; and (4) use biologically-realistic computational models that include systems-level aspects to understand the function and mechanisms by which oscillatory and other electrophysiological patterns unfold across the brain to impact cognitive, affective, or social processing. This FOA uses the R21 exploratory grant mechanism, whereas its companion FOA, PAR-21-175, seeks R01 grant applications for larger research applications that have an established premise.

Funding Website: 
PAR-21-176 

Keywords: Animal Models, Brain Disorders, Cognitive Development or Processes, Computational Neuroscience, Computer Modeling, Neural Stimulation, Neurological Disorders, Neurophysiology, Neuropsychiatry

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Application Due Date (s): October 16, 2021, February 16, 2022, June 16, 2022

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: The combined budget for direct costs for the two-year project period may not exceed $275,000, and no more than $200,000 may be requested in any single year.

Abstract: The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementia (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD. PAR-20-157 uses the R01 grant mechanism, while PAR-20-159 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. 

Funding Website: 
PAR-20-159

Keywords: Alzheimers Disease; Dementia; Neuropsychiatry

Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)

Application Due Date (s):  October 17, 2021 (LOI) | November 17, 2021 (Application)

Sponsoring Agency: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: Up to $500,000 per year in direct costs. The maximum project period is 5 years.

Abstract: This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including methamphetamine, amphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.

Funding Website:
RFA-DA-22-009

Keywords: HIV/AIDS, Neurological Disorders, Stem Cells

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Application Due Date (s): March 30, 2022 (applications accepted annually)

Sponsoring Agencies: Eunice Kennedy Shriver, National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH) United States Department of Health and Human Services (HHS)

Amount Available: $200,000 USD, 2-years

Abstract: The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices. 

Funding Website:
PAR-20-042

Keywords: Biomedical Research (Multidisciplinary), Clinical Research or Studies Musculoskeletal System, Physical Medicine and Rehabilitation

Notice of Special Interest: Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination

Application Acceptance Periods: 

• June 1, 2021 to August 31, 2021

• September 1, 2021 to November 30, 2021

• December 1, 2021 to February 28, 2022 

Sponsoring Agencies: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Amount Available: Application budget requests should rarely exceed $100,000 in direct costs per year.

Abtract: This Notice of Special Interest (NOSI) announces the availability of administrative supplements to support the dissemination of promising technologies and resources generated from active Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative awards, to foster collaborations between innovators and new end-user laboratories, and ultimately integrate such innovations into neuroscience research practice. 

The BRAIN Initiative is aimed at revolutionizing our understanding of the human brain. By accelerating the development and application of innovative technologies and resources, researchers will be able to produce a new dynamic picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. It is expected that the application of these new technologies and resources will ultimately lead to new ways to treat, cure, and even prevent brain disorders.

The goal of this NOSI is to accelerate the scientific impact of the BRAIN Initiative through rapid dissemination of promising technologies and resources to the neuroscience research community. This NOSI will support small dissemination efforts for which a clear value to the identified user group is demonstrated in the application. The proposed work must be within the scope of the original project of the eligible parent award but beyond the original dissemination plans included in the parent application.

Funding Website:
NOT-NS-21-014

Keywords: Brain, Brain Disorders, Neural Stimulation, Neurons

Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction

For applications submitted through May 7, 2023

Sponsoring Agency: National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Abstract: The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse (NIDA) about a special interest in research project applications focusing on discovery, development and validation of drug addiction biomarkers, biosignatures and elucidation of substance use disorder biotypes, with an emphasis on machine learning and artificial intelligence ( AI) based analytical approaches. Of interest are applications that focus on generating new data, as well as those integrating existing datasets to search for neurobiological and neuroclinical patterns, also in combination with peripheral biomarkers, neuroimaging, neurophysiological data, gene expression and epigenetic data. This type of research could result in an ability to compose more neurobiologically homogenous patient populations deeply profiled for clinical trials participation, enable selection and stratification of patients in studies to more precisely assess signals of therapeutic efficacy, predict a response to a therapeutic and/or behavioral intervention, as well as discover genotype-phenotype neural correlates and connect those with the proximal and distal outcomes of substance use disorders.

Funding Website:
NOT-DA-20-012 

Keywords: Addictions, Artificial Intelligence or Cybernetics, Biological Markers & Sensor Mechanisms, Clinical Research or Studies, Drugs or Drug Abuse, Gene Expression, Neuroimaging

Notice of Special Interest: Exploring the Roles of Biomolecular Condensates in Substance Use Disorder and/or HIV-related processes

For applications submitted through September 7, 2023

Sponsoring Agencies:  National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) /  United States Department of Health and Human Services (HHS)

Abstract: The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse (NIDA) of special interest in research examining the roles of biomolecular condensates (BMCs) or their regulators in processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis. The purpose of this Notice of Special Interest (NOSI) is to encourage the submission of research projects examining the roles of BMCs or their regulators in processes relevant to SUDs and/or HIV infection, latency, or pathogenesis.

Website:
NOT-DA-20-018

Keywords: HIV/AIDS, Opioids, Pathogenesis, Viral Infections

Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants

For applications submitted through September 7, 2023 

Sponsoring Agency: National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Abstract: The National Institute on Drug Abuse is issuing this Notice to highlight its interest in preclinical and clinical research to advance the understanding of the effects of concomitant use of opioids and stimulants. The use of opioids, such as heroin and fentanyl, together with stimulants, such as methamphetamine and cocaine, is increasing; and deaths attributed to using these combinations are likewise increasing (Al-Tayyib et al., 2017; Jones et al, 2019; LaRue et al., 2019). Opioid overdose causes asphyxiation due to respiratory depression and stimulant overdose causes agitation, hyperthermia, and cardiac events due to sympathetic stimulation; however, the effects of their concomitant use have not been adequately characterized. Treatment of overdose of opioid-stimulant combinations is currently based on symptoms. Studies in animals and cell culture have demonstrated that exposure to an opioid and methamphetamine together can be more toxic than either drug alone (Namiki et al., 2005; Tian et al., 2017). However, the mechanisms underlying the potentially enhanced toxicity of the combination remain unknown. Identifying how opioids and stimulants interact in combination to produce increased toxicity will enhance our ability to develop medications to prevent and treat comorbid opioid and stimulant use disorders and overdoses associatedwith this combination of drugs.

Funding Website: 
NOT-DA-20-007

Keywords: Clinical Research or Studies Drug Toxicity Opioids Pathophysiology

Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience

For applications submitted through September 7, 2023

Sponsoring Agency: National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Abstract: This Notice invites cutting edge computational approaches to utilize substance use disorder (SUD) data to its full potential and provide powerful insights into the etiology, prevention, and treatment of SUD. Research using basic or clinical approaches is appropriate. NIDA seeks applications combining computational and experimental methodologies towards understanding neurobiological mechanisms related to SUD prevention and treatment. Applications may rely on existing data or propose to collect new data towards development and validation of models. Projects are encouraged to include close collaboration between quantitative and experimental researchers with expertise in HIV/AIDS SUD neuroscience, including scientists from statistics, physics, mathematics, engineering, and computer science. Investigators are encouraged to make the data generated from these projects findable, accessible, interoperable, and reusable (FAIR) to enable secondary analysis by the research community. Similarly, investigators are encouraged to make any computational tools developed through these projects widely available to the neuroscience research community for their use and modification.

Funding Website: 
NOT-DA-20-022

Keywords: Artificial Intelligence or Cybernetics, Biological Markers & Sensor Mechanisms, Clinical Research or Studies, Etiology, Immune System, Neuroimaging, Substance Abuse

Notice of Special Interest (NOSI): Role of Astrocytes and Astrocytic Networks in Drug Abuse

For applications submitted through September 8, 2023

Sponsoring Agency: National Institute on Drug Abuse (NIDA) / National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Abstract: The purpose of this Notice is to inform potential applicants of NIDA’s interest in research project grant submissions that examine the effects of drugs of abuse on the function and functional roles of astrocytes, the structural connectivity of astrocytic networks, the generation, processing and spatiotemporal control of astrocytic activity within these networks, and the consequent effects of changes in astrocyte activity due to drugs of abuse on neuronal structure and function.

Funding Website: 
NOT-DA-20-060

Keywords: Cognitive or Behavioral Models, Drugs or Drug Abuse, Immune System, Nervous System, Neurogenesis, Neuropathology, Neurotransmitters, Synaptic Transmission

Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis

For applications submitted through May 7, 2024 

Sponsoring Agency: National Institutes of Health (NIH) / United States Department of Health and Human Services (HHS)

Abstract: NIMH and participating institutes/centers (ICs) listed above are issuing this Notice of Special Interest (NOSI) to encourage secondary analyses of data from the Human Connectome Project (HCP) including the multiple datasets in the Lifespan Human Connectome projects and the Human Connectomes Related to Human Disease. Applicants beyond the groups that originally collected the data are encouraged to apply. The analyses will serve to generate and evaluate hypotheses about the complex interrelationships among: brain structure, function and connectivity; cognitive, affective, sensory and motor processes; environmental factors; life event, social and psychosocial factors; genomic data, and clinical symptoms during development, aging, or disease. 

Funding Website: 
NOT-MH-21-175

Keywords: Aging, Biological Markers & Sensor Mechanisms, Brain Development, Cognitive Development or Processes, Genomics

Application Due Date (s):

• October 1, 2021 (LOI), December 3, 2021 (Full Proposal) - Anticipated

• May 28, 2022 (LOI), July 30, 2022 (Full Proposal) - Anticipated

• February 5, 2022 (LOI), April 16, 2021 (Full Proposal) - Anticipated

Sponsor: Alzheimer's Drug Discovery Foundation (ADDF)

Amount Available: Up to $3,000,000 for clinical trials based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.

Abstract: The ADDF seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. The Prevention Pipeline RFP supports: Studies of Cognitive Decline and Risk Reduction: Cognitive decline through aging and health conditions has been linked to an increased risk of dementia. The ADDF will consider funding programs to prevent and treat these conditions, including menopause-related cognitive symptoms, postoperative delirium and postoperative cognitive decline, mild and/or repetitive traumatic brain injury, and chemotherapy-induced decline. Methods may include epidemiology or clinical trials.

Eligibility: Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged. Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.

Funding Website: 
ADDF Grants

Keywords: Alzheimers Disease, Clinical Trials, Dementia, Epidemiology, Preventive Medicine

Application Due Date (s):

• October 1, 2021 (LOI), December 3, 2021 (Full Proposal) - Confirmed

• May 28, 2022 (LOI), July 30, 2022 (Full Proposal)- Anticipated

• February 5, 2022 (LOI), April 16, 2021 (Full Proposal) - Anticipated

Sponsor: Alzheimer's Drug Discovery Foundation (ADDF)

Amount Available: Up to $600,000 based on stage and scope of research. Average Duration: One year with potential for follow-on funding. Multi-year proposals can be considered. Allowable Only direct costs are allowed.

Abstract: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on: developing novel PET ligands for clinical trials supporting novel CSF biomarkers validating established MRI approaches in larger cohorts; Novel biomarkers of neuroinflammation, synaptic integrity, autophagy and TDP-43 are high priority. Other target areas of interest include: Neuronal loss, Vascular injury and blood-brain barrier integrity. Mitochondria and metabolic function. Protein misfolding. Oxidative stress, White matter changes, Lewy body dementia, Other novel targets supported by compelling biological rationale and connection to disease.

Eligibility: Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are encouraged. Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.

Funding Website: 
ALZ_Discovery

Keywords: Alzheimers Disease, Biological Markers & Sensor Mechanisms, Dementia, Neuroimaging

*Anticipated* Application Due Date(s): November 2, 2021 (LOI) ; January 19, 2022 (Full Proposal)

Sponsor: The Foundation of the American Society of Neuroradiology (ASNR)

Amount Available: $120,000 

Abstract: The Collaborative Neuroimaging Research Grant was created to foster innovative collaboration between neuroradiology physicians and scientists. This grant is intended to provide joint collaborative opportunities for MD, PhD, and MD-PhD investigators to work together in advancing the science of neuroradiology. Scientific research is the foundation upon which the clinical practice of neuroradiology is built. Partnerships between neuroradiology clinicians and scientists have traditionally led the development, translation, and implementation of new imaging technologies and image-guided procedures. The directive of this award is to train physicians and scientists in collaborative neuroimaging research. Although any research area in neuroradiology will be considered, the award emphasizes the development of innovative diagnostic and interventional neuroradiology techniques, or basic science research with a translational component.

Funding Website: 
ASNR Awards

Keywords: Neuroimaging / Neurology / Radiology & Medical Imaging

*Anticipated* Application Due Date (s): November 2, 2021 (LOI)  |  19 January 19, 2022 (Full Proposal) 

Sponsor: The Foundation of the American Society of Neuroradiology (ASNR)

Amount Available: The total award amount is up to $60,000 for one year (direct costs only). 

Abstract: The Foundation of the ASNR Research Grant in Artificial Intelligence is created to provide a funding opportunity for investigators who are not fully established as neuroimaging researchers and who are interested in the emerging field of artificial intelligence in neuroradiology. Scientific research remains the foundation upon which the clinical practice of neuroradiology is built, and artificial intelligence is likely to have a transformative influence on the field of neuroimaging. Researchers in artificial intelligence will become the leaders who develop and translate this emerging technology into the routine clinical care of patients and go on to obtain extramural funding to support their research program. The overarching goal of this grant initiative is to foster the growth of individuals in this important and rapidly evolving field of artificial intelligence. Although any research in the field of artificial intelligence will be considered, the award emphasizes the application or translation of artificial intelligence methodology into neuroimaging practice including work flow, health services and access, diagnosis, treatment management, outcome assessment, prognostication, and biomarker development.

Eligibility: A candidate must be a member of ASNR in good standing with an MD or DO degree, and must be board-certified or board-eligible in Radiology by either the American Board of Radiology or the Royal College of Physicians and Surgeons of Canada (RSPSC). A candidate must have completed a residency in Diagnostic Radiology and be enrolled in or have completed an ACGME-approved fellowship in neuroradiology or a fellowship in Pediatric Neuroradiology by the award period. Junior faculty are encouraged to apply. In some circumstances, the award may be appropriate for mid-level faculty wishing to alter their research path. The award is not intended for established or senior investigators. Ideally, the candidate should have access to a mentor with working knowledge of artificial intelligence, both machine learning and deep learning. If the AI mentor is not a senior ASNR member, then the candidate should seek additional mentorship from an ASNR senior member, who can assist as an overall project supervisor. Attendance to the ASNR/ASFNR AI workshop and/or active participation to the activities of the ASNR study group are encouraged.

Funding Website: 
ASNR_Foundation

Keywords: Artificial Intelligence or Cybernetics, Neuroimaging, Neurology, Radiology & Medical Imaging

*Anticipated* Application Due Date (s):  November 2, 2021 (LOI)  |  January 19, 2022 (Full Proposal) 

Sponsor: The Foundation of the American Society of Neuroradiology (ASNR)

Amount Available: The total award amount is up to $60,000 for one year (direct costs only). 

Abstract: The Scholar Award in Neuroradiology Research was created to provide funding opportunities for investigators not yet professionally established in neuroimaging research, and to obtain experience and competency in newly developing fields within neuroradiology. Scientific research is the foundation upon which the clinical practice of neuroradiology is built. Neuroradiologists must be leaders in the development of new imaging technologies and image- guided procedures, as well as in assessment of the roles of these technologies and procedures in the care of patients. The directive of this award is to train individuals in neuroscience research in important areas. Although any research area in neuroradiology will be considered, the awards emphasize the application of techniques in basic science research to diagnostic and/or interventional neuroradiology.

Funding Website: 
ASNR_Foundation

Keywords: Neuroimaging, Radiology & Medical Imaging

Application Due Date (s):   January 4, 2022 - Anticipated / sponsor 

Sponsor: McKnight Foundation Endowment Fund for Neuroscience 

Amount Available: Up to $225,000, 3-years

Abstract: The Scholar Awards support young scientists who: hold an M.D. and/or Ph.D. degree; have completed formal postdoctoral training; and demonstrate a commitment to neuroscience. The Endowment Fund especially seeks applicants working on problems that, if solved at the basic level, would have immediate and significant impact on clinically relevant issues. McKnight Scholars have generated some key findings about neuroscience, including: The discovery of receptors that encode the senses of smell, taste, and thermal pain. The first crystal structure of one of the ion channels that control the excitability of neurons. The discovery of neurotrophic factors that promote neuronal survival. The identification of molecules that promote axon growth and regeneration in the nervous system. The discovery of proteins in the nerve terminal that mediate the release of neurotransmitters. The identification of genes that control short- and long-term memory.

Eligibility: Candidates for the McKnight Scholar Awards must have: An M.D., Ph.D., or other suitable doctorate / A record of meritorious research / Evidence of a commitment to a career in neuroscience / Full-time appointment at the rank of Assistant Professor / and must have served at that rank for less than four years at the application deadline. Scientists holding other titles such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility. Documentation that the sponsoring institution has government approval for the applicant to work in the U.S.

Funding Website: 
McKnight Scholar Awards 

Keywords: Clinical Research or Studies, Human Learning and Memory, Learning Disorders, Neurological Disorders, Neuroscience

*Anticipated* Application Due Date: February 1, 2022

Sponsor: Sidney R. Baer, Jr. Foundation

Amount Available: Previous years' grants have ranged from $4,000 to $1,267,950.

Abstract: The Sidney R. Baer, Jr. Foundation is a catalyst for positive change in the lives of those living with schizophrenia and bipolar disorder. It is their mission to award grants to individuals, organizations, and institutions doing work that will have a tangible impact on the field of mental health. Their vision is a better world, where those afflicted with schizophrenia and bipolar disorder might no longer feel the isolation so often associated with the disease. Grant categories: Education, Criminal Justice, Reintegratio, Clinical Research, Social Support.

Eligibility: Qualifying organizations must have tax-exempt status under IRS sections 501(c)(3) and 509(a)(1) or 509(a)(2). They must agree to expend no more than seven percent of the received fund on the organization’s administrative expenses and the primary focus of the application should be programs concentrating on schizophrenia and bipolar disorder.

Funding Website: 
Baer_Foundation

Keywords: Affective Disorders, Mental Health, Schizophrenia

*Anticipated* Application Due Date (s):  Jun, 1, 2022, project period, 3-years

Sponsor: One Mind Institute (formerly IMHRO)

Amount Available: Up to $300,000

Abstract: The goal of the One Mind Rising Star Research Awards is to build capacity and accelerate research on neuropsychiatric disorders by recognizing and funding promising, early career investigators through a competitive grants process. One Mind, in collaboration with Inscopix, is also offering up to two supplemental technology grants, each in support of one Rising Star Research Award. The scope of the three 2021 Rising Star Awards varies as described below. Applicants will be considered for all that fit their proposal. The One Mind / Janssen Rising Star Award in Memory of Jeffrey S. Nye, MD, PhD, is open to proposals for translational research on any neuropsychiatric disorder. The One Mind Robina Riccitiello Rising Star Depression Research Award is open to proposals for translational and clinical research on depression and related disorders. The One Mind Donna Friedman Rising Star Eating Disorders Research Award is limited to translational and clinical research on eating disorders, such as anorexia nervosa, bulimia or compulsive eating disorders. Examples of relevant research proposals include, but are not limited to, studies that aim to: Discover causal mechanisms, biomarkers and therapeutic targets for neuropsychiatric disorders; Evaluate the effectiveness of therapies, including pharmaceuticals, electroceuticals, digital therapies or cognitive and behavioral health interventions to prevent the onset or promote recovery of neuropsychiatric disorders; Investigate common mechanisms of brain dysfunction and/or recovery between two or more neuropsychiatric or neurological disorders to accelerate the development of diagnostic tools, effective treatments and precision medicine; Improve our understanding of how age, race/ethnicity, and/or comorbidities impact the diagnosis, prognosis and treatment effectiveness of neuropsychiatric disorders; Integrate preclinical and clinical studies to accelerate and enhance translational research on neuropsychiatric disorders and recovery.

Eligibility: To qualify as an early career investigator, candidates should be within 10 years of their initial independent appointment as an assistant professor for academic institutions or equivalent for non-academic research institutions. Note that postdoctoral fellows are ineligible.

Website:
OneMind Rising Star

Keywords: Behavioral Pharmacology, Behavioral Problems or Disorders, Brain Disorders, Clinical Research or Studies, Medical Technology, Mental Depression, Mental Health, Neuropsychiatry, Schizophrenia, Traumatology, Accidents & Injury

**Anticipated** Application Due Date (s):  June 15, 2022 (LOI) | June 30, 2022 (Full Proposal)

Sponsor: 1907 Research 

Amount Available: $120,000 

Abstract: The 1907 Trailblazer Award was established to encourage high-impact, step-change approaches to research in the brain and mind sciences for mental health. In addition to supporting a specific research project, the Award intends to increase the size of the talent pool of early career investigators researching causes; cures for mental illness. Projects must be grounded in the study of biological mechanisms underlying brain function, cognitive processes, and/or consciousness. We support projects for basic science in addition to near-term applications (e.g. disruptive technologies and potential clinical interventions). *Limited submission** Each university/research institution may select up to two candidates.

Eligibility: This award is open to all universities/research institutions in the US, the UK, or Canada. Applicants must be within ten years of the date when PhD/MD degree was awarded. For clinical scientists, the 10-year clock starts upon completion of all residency and fellowships. Please use April 16, 2022 as the end date for calculation of the 10-year period. Applicants will currently be employed by a university or public research institute in the US, the UK, or Canada, with full-time employment guaranteed for the duration of the project.

Website: 
1907 Research 

Keywords: Clinical Psychology, Cognitive Psychology, Genetics, Mental Health, Neuroimaging, Neurological Disorders, Neurology, Neuroscience, Psychiatry, Psychology

Important Dates: 24 Jun 2022 - (LOI, Anticipated) |  28 Sep 2022 - (Applicaton, Anticipated)

Sponsoring Agency: Brain Research Foundation (BRF)

**Limited submission** BRF will only accept one LOI per institution.

Amount Available: Each total award is limited to $150,000 (direct costs) for a two year grant period. Exact dates will be provided by the BRF upon application approval. Funds must be utilized within the grant period

Abstract: Brain Research Foundation's Scientific Innovations Award Program provides funding for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting edge research in well-established research laboratories, under the direction of established investigators. The objective of the SIA is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high impact journals Funding Preferences:Funding is to be directed at projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. This should be a unique project for senior investigators who are encouraged to stretch their imagination into areas that can substantially change an area of research. Funding of research projects that will likely lead to successful grant applications with NIH and other public and private funding entities.

Eligibility:  The nominated candidate must be a full-time associate professor or full professor at an invited US academic institution, working in the area of studies of brain function in health and disease. Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position. Scientists that have previously received a BRF Scientific Innovations Award may not receive the award for a second time until five years has elapsed since the beginning date of the prior award. Grant requirements from all previous awards must be met. Only one PI may apply per application.

Funding Website:
Scientific-Innovations-Award

Keywords: Behavioral Problems or Disorders, Brain, Clinical Research or Studies, Mental Health, Neuroscience, Sensory Integration Disorders, Sensory System

Application Due Date (s): September 30, 2021

Sponsoring Agency: American Psychiatric Association (APA)

Amount Available: $1,500 & $20,000. Award includes: $1,500 to the senior researcher awardee, $20,000 to the awardee. Engraved Plaque. 

Abstract: The Kempf Fund Award for Research Development in Psychobiological Psychiatry, established in 1988, recognizes a senior researcher who has made a significant contribution to research on the causes and treatment of schizophrenia as both a researcher and a mentor. An award is also made to support the career development of a young research psychiatrist working in a mentor-trainee relationship with the award winner. Funded by the estate of Dorothy C. Kempf.

Eligibility: The senior researcher and young research psychiatrist must be: Psychiatrists, Citizens or Permanent Residents of the U.S. or Canada

Funding Website:
Kempf-Fund-Award

Keywords: Psychiatry, Psychobiology

*Anticipated* Application Due Date (s): November 2, 2021

Sponsoring Agency: The Foundation of the American Society of Neuroradiology (ASNR)

Amount Available: $60,000 per year (direct costs only)

Abstract: The Comparative Effectiveness Research Award in Neuroradiology was created to support. investigators in the generation and synthesis of evidence that compares the benefits and harms of diagnostic imaging methods or interventions to prevent, diagnose, treat and monitor a clinical condition or to improve the delivery of care. Comparative Effectiveness Research (CER) is valuable to clinicians, patients, purchasers, and policy makers in making informed decisions that will improve health care at both the individual and population levels. For example, CER projects may include the direct comparison of diagnostic imaging modalities or interventions for a specific disease in a study population. Neuroradiologists have an important role in the development of new imaging technologies and image-guided procedures, as well as in the assessment of these techniques in the clinical care of patients. The total award amount is up to $60,000 per year (direct costs only), which will be paid in two equal installments on July 1st and March 1st of the year of the award. The recipient will present his/her research at the ASNR 60th Annual Meeting in New York, NY, May 13-17, 2022, and receive an invitation to the President's Reception during that same time.

Eligibility: A candidate must be a member of ASNR in good standing with an MD or DO degree, and must be board-certified or board-eligible in Radiology by either the American Board of Radiology or the Royal College of Physicians and Surgeons of Canada (RSPSC). A candidate must have completed a residency in Diagnostic Radiology and be enrolled in or have completed an ACGME-approved fellowship in neuroradiology or a fellowship in Pediatric Neuroradiology by the award period. Junior faculty are encouraged to apply. The candidate must be under the direct supervision of an ASNR Senior Member, who is willing to act as a mentor and project supervisor.

Funding Website: 
ASNR Awards and Honors Information

Keywords:  Medical Diagnosis Neuroimaging Neuroscience Radiology & Medical Imaging Technology Assessment or Transfer (Medical)

*Anticipated* Application Due Date (s): May, 07 2022 (LOI) | July 30, 2022 (Full Proposal)

Sponsoring Agencies: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium Rare Diseases Clinical Research Network (RDCRN)

Amount Available: up to $60,000, 1-year

Abstract: TheCReATeConsortium, a NIH-funded Rare Diseases Clinical Research Consortium, in partnership with the ALS Association, is pleased to announce this request for applications (RFA) to support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies. Proposals to developeitherwet(e.g. biofluidbased) ordry (e.g. neuroimaging, neurophysiological) biomarkers are encouraged. Investigators submitting an application in response to this RFA may also request to use the data and/or biological samples collected by the CReATe Consortium.

Eligibility: Any individual with the requisite scientific training, irrespective of country of residence or origin, may submit an application in response to this RFA.

Funding Website:
CReATe

Keywords: Amyotrophic Lateral Sclerosis, Biological Markers & Sensor Mechanisms, Neurodegenerative Diseases, Neuroimaging, Neurophysiology, Orphan Rare Diseases

Application Due Date (s): 01 Jun 2022 - Anticipated / sponsor 

Sponsoring Agency: Science Directorate American Psychological Association (APA)

Amount Available: not specified

Abstract: The APA Distinguished Scientific Awards for an Early Career Contribution to Psychology honor early career scientists for contributions in the first 9 years post-PhD. For the purpose of this award, psychology has been divided into 10 areas: animal learning and behavior, comparative developmental, health cognition/human learning, psychopathology, behavioral and cognitive neuroscience, perception and motor performance, social psychology, applied research (e.g., treatment and prevention research, industrial/organizational research, educational research), individual differences (e.g., personality, psychometrics, mental ability, behavioral genetics). Five areas are considered each year, with areas rotated in 2-year cycles.

Eligibility: For the 2022 program, nominations of persons who received doctoral degrees during and since 2012.

Funding Website:
APA Awards

Keywords: Animal Behavior or Ethology, Applied Sciences, Cognitive Development or Processes, Genetics, Human Learning and Memory, Neuroscience, Psychology, Psychopathology, Quantitative Psychology, Social Sciences, Visual Perception

*Anticipated* Application Due Date (s): November 9, 2021.

Sponsoring Agency: Department of Psychiatry, Columbia University

Amount Available: The award provides a stipend, commensurate with experience. The stipend provided may require supplemental funding by the mentors.

Abstract: The Paul Janssen Fellowship is awarded to an outstanding young physician-investigator to conduct novel translational research in the field of neuroscience as it relates to psychiatric disease and medicine. The Paul Janssen Fellow will be assigned both a basic scientist mentor and a clinical investigator mentor from the faculty at Columbia University to serve as joint mentors. The fellow will take a basic observation made by the basic science mentor and apply it to the study of disease or treatment with the clinical research mentor.

Eligibility: Candidates from the international neuroscience community, holding an M.D. or Ph.D. degree, and preferably having completed initial fellowship research training, are invited to apply. Fellows at Columbia University or the New York State Psychiatric Institute/RFMH are encouraged to submit applications. **Faculty are not eligible.

Funding Website:
Janssen_Fellowship

Keywords: Neuropsychiatry Neuroscience

*Anticipated* Application Due Date (s): November 30, 2021.

Sponsoring Agency: Department of Psychiatry Columbia University

Amount Available: There are six positions in the fellowship. Two to three new fellows enter each year.

Abstract: This fellowship focuses on research strategies, basic and clinical, related to schizophrenia and psychotic disorders. Supervised research, training in statistics and research methodology, and didactic seminars on schizophrenia comprise the two- to three-year program, which is supported by a National Institute of Mental Health (NIMH) grant.

Eligibility: MD preferably with completed psychiatric or neurological residency, or PhD with research experience in this area. U.S. citizen or permanent resident.

Funding Website: 
Fellowship_Schizophrenia

Keywords: Clinical Research or Studies, Mental Health, Psychiatry, Schizophrenia

*Anticipated* Application Due Date (s): December 2, 2021

Sponsoring Agency: Autism Science Foundation (ASF)

Amount Available: $25,000-35,000 USD

Amount Note: Foundation will make a number of awards determined by its available financial resources. The term of the award will be a period of one year and will include: For predoctoral and medical students: $25,000. For postdoctoral students: $35,000. This award cannot be used to cover tuition payments. No portion of these funds shall be used to cover indirect university costs.

Abstract: The Autism Science Foundation invites applications for its Pre-and Postdoctoral Training Awards from graduate students, medical students and postdoctoral fellows interested in pursuing careers in basic and clinical research relevant to autism spectrum disorders. The proposed training should be scientifically linked to autism but may be broadened to include training in a closely related area of scientific research. Autism Science Foundation will consider all areas of related basic and clinical research including but not limited to: human behavior across the lifespan (language,learning, behavior, communication, social function, motor skills; planning, epilepsy, sleep, repetitive disorders), neurobiology (anatomy, development, neuroimaging), pharmacology, behavioral intervention,neuropathology, genetics and gene/environment interactions, epigenetics, genomics, epigenomics,immunology, molecular and cellular mechanisms, studies employing model organisms and systems, and studies of treatment and service delivery, and dissemination of research findings. Special consideration will be given to projects focusing on traditionally under-researched populations, medical comorbidities of autism, a genetically-defined subtype of autism, and studies of families with a high probability of receiving a diagnosis.

Eligibility: Applicants for predoctoral awards must be enrolled students in good standing in a program leading to a research doctorate such as a Ph.D. or Sc.D. or a dual degree such as an M.D./Ph.D. in an academic department at an accredited university or health/medical institution.  Applicants for Medical School Gap Year Research Training Awards should be enrolled at an accredited university medical school. Medical school applicants must apply prior to graduation from medical school but the gap year may be taken immediately after graduation. Applicants for postdoctoral awards must have completed their doctoral or medical degree and have been accepted as a postdoctoral fellow in good standing in a program as of the award start date (July-Sept 2020). U.S. citizens enrolled in universities inside or outside of the United States are eligible to apply. Non-US citizens enrolled in universities based inside or outside of the U.S. are also eligible to apply.

Funding Website: 
ASF Fellowship

Keywords: Autism, Behavioral Pharmacology, Clinical Research or Studies, Epigenetics, Epilepsy, Genetics, Genomics, Immunology, Medical Treatment, Neuroanatomy, Neurobiology, Neuropathology, Pharmacy & Pharmacology, Sleep & Sleep Disorders

*Anticipated* Application Due Date (s): January 22, 2022, March 5, 2022

Sponsoring Agency: Educational Testing Service (ETS)

Amount Available: $28,000 USD

Abstract: The fellowship provides funding for promising graduate students in psychometrics, or a related field, who are conducting innovative, applied research. Selected fellows will carry out their proposed research under the mentorship of their academic advisor and in consultation with their ETS mentors over the course of the funding. The fellowship begins with the selected fellows working on their research as part of the Summer RMS Internship Program, where they will be provided with guidance from ETS&rsquo;s leading researchers. During the subsequent academic year, fellows study at their universities and carry out research under the supervision of an academic mentor and in consultation with their ETS mentor.<br/> <br/> The goal of this program is to increase the number of well-trained scientists in educational assessment, psychometrics and statistics. Dissertation topics in the areas of psychometrics, statistics, educational measurement or quantitative methods will be given priority.

Funding Website: 
Gulliksen Fellowship 

Eligibility: At the time of application, candidates must be enrolled in a doctoral program, have completed all the coursework toward the doctorate, and be at the dissertation stage of their program.

Keywords: Educational Tests & Measurements, Quantitative Psychology, Statistics

*Anticipated* Application Due Date (s): February 15, 2022

Sponsoring Agency: Esther A. and Joseph Klingenstein Fund, Inc.

Amount Available: "$225,000 USD. The award of $225,000 is payable over a three-year period beginning July 1. 

Abstract: The Klingenstein-Simons Fellowship supports early-career investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. Several areas within neuroscience are of particular interest: Cellular and molecular neuroscience. Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior. Neural systems. Studies of the integrative function of the nervous system. Translational research. Studies designed to improve our understanding of the causes, prevention, diagnosis, and treatment of neurological and psychiatric disorders.

Eligibility: To qualify for an award, investigators must hold a Ph.D. and/or an M.D, and have completed all research training, including post-doctoral training. Candidates must also meet these four qualifications: The candidate must have a tenure track appointment or equivalent. A letter indicating the commitment of institutional resources to establish the investigator and the prospects for long-term support by the institution must be provided by an institutional official (e.g., dean), including date of appointment. The candidate must be an independent investigator at a university, medical center or research institute with no more than four years having passed since completing postdoctoral training and the start of his/her tenure track or equivalent appointment. U.S. citizenship is not a requirement, but it's expected that candidates will be permanent residents of the U.S. and their research will be conducted in U.S. institutions. Applicants must inform the EAJK Fund of other sources of funding. Although there's no strict prohibition against holding more than one fellowship at one time, the Fund may take other funding into account when deciding whether to grant an Award. Applications will be reviewed, and selections made, by a Scientific Advisory Committee of distinguished neuroscientists.

Funding Website: 
joseph-klingenstein-fund

Keywords: Clinical Trials, Epilepsy, Nervous System, Neural Stimulation, Neurological Disorders, Neuroscience, Psychiatry

*Anticipated* Application Due Date (s): April 23, 2022

Sponsoring Agency: Amyotrophic Lateral Sclerosis (ALS) Association

Amount Available: $150,000 USD total, project time two years

Abstract: The ALS Association is proud to support the development of new scientists through the Milton Safenowitz Postdoctoral Fellowship. These awards are to encourage and facilitate promising young scientists to enter the ALS field. Fellows work with a senior mentor and receive extensive exposure to the ALS research community through meetings and presentations. Topics of Interest (Scope): We are especially interested in Fellowships supporting the following: Studies for new target validation including in animal models, and human cell models. Studies that would elucidate target or pathway biology in disease-relevant models, including defining upstream/downstream modifiers and convergence of promising target pathways. Studies of risk factors that could ultimately reduce the risk of developing ALS including studies of genetic risk factors, epigenetics, gene-environment interactions, lifestyle, occupational or dietary factors and epidemiology. Studies of new biomarker identification, and development and/or validation of biomarker assays. Studies to help people living with ALS, including development and/or validation of novel assistive technology and measurement of patient/caregiver/family burden.

Eligibility: Individuals who have the skills, knowledge, and resources necessary to carry out the proposed research and have an existing postdoctoral fellowship, including the support of their mentor. Applicants who have been fellows for less than two years by the time the award starts are eligible to apply.

Funding Website: 
ALS Fellowship

Keywords: Amyotrophic Lateral Sclerosis, Animal Models, Epidemiology, Epigenetics, Genetics, Neurodegenerative Diseases

Application Due Date (s): Ongoing

Sponsoring Agency: Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Medicine, Stanford University

Amount Available: Amount Note: Salary is commensurate with experience. The Division also has an NIH T32 that allows the candidate to apply for independent funding if desired.

Abstract: Applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in Psychology and human neuroimaging are also encouraged to apply. Applicants should be experienced at designing and implementing cognitive neuroscience experiments. Preferences given to candidates who have experience with conducting fMRI studies, working with MRI scanners, processing MRI and fMRI datasets, and running neuroimaging data analysis using software packages, such as Matlab, SPM, FSL E-Prime, and AFNI. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.

Eligibility: Applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in Psychology and human neuroimaging are also encouraged to apply. Applicants should be experienced at designing and implementing cognitive neuroscience experiments. Preferences given to candidates who have experience with conducting fMRI studies, working with MRI scanners, processing MRI and fMRI datasets, and running neuroimaging data analysis using software packages, such as Matlab, SPM, FSL E-Prime, and AFNI. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.

Funding Website:
Stanford Postdoc Opening

Keywords: Chronic Pain, Cognitive Science, Magnetic Resonance Imaging, Neuroimaging

Application Due Date (s): Ongoing

Sponsoring Agency: Stanford Medicine Stanford University

Amount Available: The postdoctoral fellow will be responsible for designing experiments, conducting ongoing imaging, analyzing neuroimaging data, planning future studies, searching literature, and writing for publication. The fellow will have opportunity to work within a large group of interdisciplinary Stanford researchers involved with multiple studies ongoing of chronic pain.

Abstract: The Systems Neuroscience and Pain Laboratory at Stanford University is currently accepting applications for a postdoctoral fellow for neuroimaging research in chronic pain. Funded by NIH (co-PIs Sean Mackey, Gary Glover), this project's overall goal is to characterize pain mechanisms in humans and to develop objective biomarkers of chronic pain. We will be specifically characterizing central sensitization and descending modulation utilizing novel simultaneous neuroimaging technology for spinal cord, brainstem, and brain. The successful candidate will have unique opportunity to engage in simultaneous spinal cord/brain fMRI and to advance spinal cord fMRI acquisition/analysis and biomarker development. Research plans include:1. Study of functional connectivity between spinal cord and brain. 2. Characterization of corticospinal pain signature. 3. Physiological noise modeling in spinal cord. 4. Refinement of multiecho spinal cord acquisition and analysis pipeline.

Eligibility: Applicants should hold a PhD and experience conducting fMRI studies and analysis. Previous experience in spinal cord imaging research is an advantage.

Funding Website: 
stanford_research-positions

Keywords: Biological Markers & Sensor Mechanisms, Brain, Chronic Pain, Neurology, Spinal Cord Injury

Application Due Date (s):  Ongoing

Sponsoring Agency: Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Medicine, Stanford University

Amount Available: The positions are for 1-3 years.

Abstract:The Stanford Division of Pain Medicine Training Program in Pain and/or Substance Use Disorders is intended to develop postdoctoral trainees' skills to become independent investigators in the fields of pain, substance abuse disorders, and their intersection. The training program incorporates required and elective coursework, mentored research experiences, an individual integrated research project, seminars, and exposure to professional development skills, including grant proposal and manuscript writing. The aim of this program is to develop the next generation of academic leaders in pain and substance abuse disorder to ultimately can better characterize these important conditions and translate discoveries into safe and effective treatments. The postdoctoral fellow may work with one of 17 primary mentors, spanning 7 departments - Anesthesiology, Neurobiology, Medicine, Psychiatry, Biology, Radiology, and Psychology. Disciplines in which the division offers training include: Molecular and cellular biology, Optogenetics, Electrophysiology, Glia, "Omics" (genomics, proteomics, metabolomics), Neuroimaging, Cognitive neurosciences, Psychology, Clinical trials, Pharmacology, Outcomes, Health Policy and Economics. The T32 also provides tuition support to obtain Stanford Masters in Epidemiology and Clinical Research for those who would benefit from additional training in clinical research.

Eligibility: To be appointed to a research training grant, an individual must be a citizen, a non-citizen national of the United States or must have been lawfully admitted for permanent residence (i.e., in possession of a current, valid Alien Registration Receipt Card I-551, or must be in possession of other legal verification of such status) and not be supported by any other NIH grant at the time of the T32 appointment. Individuals on temporary or student visas are not eligible. <br/><br/>Trainees must have received, as of the beginning date of the appointment, an MD/PhD, MD or PhD or comparable doctoral degree from an accredited domestic or foreign institution. Written certification by an authorized official of the degree-granting institution that all degree requirements have been met, prior to the date training is to begin, is acceptable.<br/><br/>Applications are encouraged from members of under-represented minority groups. Stanford is a non-discriminatory/affirmative action equal opportunity employer.

Funding Website:
Stanford Research Postions

Keywords: Pain, Substance Abuse, Substance Abuse Treatment

Application Due Date (s):  Ongoing

Sponsoring Agency: Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Medicine, Stanford University

Amount Available: Salary is commensurate with experience.

Abstract: The Systems Neuroscience and Pain Laboratory at Stanford University is currently accepting applications for a postdoctoral research fellow to advance Transcranial Magnetic Stimulation (TMS) in chronic pain. The lab uses state of the art technologies, including TMS, fMRI, and structural MRI, and has had a growing focus in machine learning techniques applied to neuroimaging, psychophysics and genetics. The primary role will be to advance the use of TMS to understand and treat pain. Additionally, the candidate will have the opportunity to interact with a large and growing group of interdisciplinary Stanford researchers involved with multiple studies involving acute and chronic pain including: real-time fMRI control of brain activity, spinal cord fMRI, pharmacologic fMRI, individual difference in pain and cognitive/affective dimensions of pain. The postdoctoral fellow will be responsible for conducting ongoing TMS projects, analyzing neuroimaging data, as well as planning and conducting future studies. Duties will also include manuscript preparation and management of research assistants. The most successful applicants will have a demonstrated interest in pursuing publication and grant opportunities. Facilities include multiple research-dedicated 3T MR scanners and a 7T full-bore MR scanner, as well as near-infrared spectroscopy and transcranial magnetic stimulation.

Eligibility: Applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. MD or other graduate-level applicants are also encouraged to apply and should have applicable research experience. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in human neuroimaging are also encouraged to apply. <br/><br/>Applicants should be experienced at conducting TMS studies, and additional experience with neuroimaging (MRI, fMRI) is preferred. Some experience with software packages such as SPM, FSL, AFNI, and Matlab is preferred. Experience with presentation software (such as E-Prime) and other programming languages such as C a plus, but not a requirement. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.

Funding Website: 
Stanford Research Postions

Keyowrds: Chronic Pain Neural Stimulation Neuroimaging Neuroscience

Application Due Date (s): Ongoing

Sponsoring Agency: Yale School of Medicine Yale University

Amount Available: not specified

Abstract: The Neuroimaging Sciences Training Program (NISTP) in Addiction trains scientists in technological aspects of data acquisition and analysis, clinical and biological fundamentals in areas of interest to each trainee as related to substance abuse and dependence, development of research proposals, and generation of documentation to navigate today's administrative requirements for imaging research. The program is designed to last 2-3 years, and the purposes of the program are the following: Provide formal course training to postdoctoral fellows, with an emphasis on imaging and clinical research methodology, and instruction in their underlying multidisciplinary sciences. Provide mentored training for fellows to apply these new methods to the interdisciplinary advance of our understanding of the function of the brain in substance use disorders. Provide an integrated research experience for fellows in both imaging applications and methodology. All fellows will be expected to complete at least one research project with an applications and one with a methodology mentor during their training period. Each fellow will work on two projects: one focused on methodology and one focused on an application in substance use. There will be two mentors, one for each of the projects, and it is the fellow's choice which will be the primary mentor and associated area of work.

Eligibility: Applicants must have U.S. citizenship or permanent resident status.

Funding Website: 
Yale University

Keywords: Addictions, Brain, Data Management or Analysis (Medical), Neuroimaging, Substance Abuse

*Anticipated* Application Due Date (s): October 15, 2021 

Sponsoring Agency: SHAPE America (Society of Health and Physical Educators)

Amount Available: Not specified

Abstract: The purpose of this scholarship is to assist graduate students focusing on psychomotor measurement and evaluation in paying their professional expenses.The recipient must demonstrate potential for succeeding in both the degree program and as a professional in psychomotor measurement and evaluation.

Eligibility: The recipient shall:Be a current member of SHAPE America and the Measurement and Evaluation be presently a masters or doctoral student pursuing studies focusing on psychomotor measurement and evaluation at a college or university in the United States; have at least one more academic year of training after receiving the scholarship. Priority will be given to candidates who have completed the first year of their degree program.

Funding Website: 
SHAPE Grad. Award

Keywords: Developmental Disabilities, Intellectual Disabilities, Quantitative Psychology, Social or Recreation Services for People with Disabilities

Application Due Date (s): October 31, 2021

Sponsoring Agency: Psychometric Society

Amount Available: See funding website.

Abstract: The Psychometric Society Dissertation Prize recognizes at most one outstanding Ph.D. dissertation each year, written in any field covered by the journal Psychometrika. Criteria include the originality and rigor of the research, possible applications of the theory or methods and potential impact.

Funding Website: 
Dissertation Prize

Keywords:  Analytical Psychology, Applied Psychology, Behavioral or Experimental Psychology, Clinical Psychology, Cognitive Psychology, Comparative Psychology,  Developmental Psychology, Educational Research, Experimental Psychology, Quantitative Psychology, Science Journalism

*Anticipated*  Application Due Date (s): February 1, 2022

Sponsoring Agency: Educational Testing Service (ETS)

Amount Available: $7,500

Abstract: If you are a creative and innovative individual who wants to help shape the future of learning and assessment, we encourage you to apply for the 2021 Summer Research and Measurement Sciences (RMS) Internship program. Steeped in decades of broad expertise, RMS conducts rigorous foundational and applied research on the most critical issues facing education and the workforce. Central to ETS&rsquo;s legacy of global leadership in learning and assessment, RMS is dedicated to advancing the science and practice of measurement, driving innovation in digital assessment, learning and teaching. Interns who are accepted into the program will collaborate with scientists on projects related to these topics and will participate in data analysis, writing and other research tasks. Doctoral students who have completed at least two years in one of these or a related field are encouraged to apply. Upon the completion of the program, you&rsquo;ll have the opportunity to present your findings to teams across.

Eligibility: Current full-time enrollment in a relevant doctoral program. Completion of at least two years of coursework toward the doctorate prior to the program start date.

Funding Website: 
summer-rms-intership

Keywords: Career Education and Planning, Educational Evaluation, Educational Research, Educational Tests & Measurements, Human Learning and Memory, Instructional Technology, Linguistics or Philology, Quantitative Psychology, Statistics, Technology Education

*Anticipated* Application Due Date (s): April 22, 2022

Sponsoring Agency: American College of Neuropsychopharmacology (ACNP)

Amount Available: See sponsor's website.

Abstract: The American College of Neuropsychopharmacology (ACNP) annually selects distinguished young scientists in the field of neuropsychopharmacology to be part of our travel award program. Any scientist worldwide is eligible to apply for a travel award. All candidates must be eligible in one of the three applicant tiers AND meet training/post training limits. Candidates from underrepresented populations in science and medicine are highly encouraged to apply. Please note, ACNP members (all categories of membership) and previous Travel Awardees are not eligible to apply.

Funding Website:
Annual Meeting Travel Award

Keywords: Adverse Effects, Behavioral Pharmacology, Neuropharmacology, Neuropsychopharmacology, Psychopharmacology

Application Due Date (s):  June 14, 2022 (Conference Proposals)

Sponsoring Agency: National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences

Amount Available: $2,000

Abstract: The PAC program funds theoretically motivated research on a wide-range of topic areas focused on typical human behavior. The aim is to enhance the fundamental understanding of perceptual, motor, and cognitive processes and their interactions. Central research topics for consideration by the program include vision, audition, haptics, attention, memory, reasoning, written and spoken language, and motor control. The program welcomes a wide range of perspectives, such as individual differences, symbolic computation, connectionism, ecological, genetics, nonlinear dynamics, and complex systems, and a variety of methodologies including both experimental studies and modeling. The PAC program is open to co-review of proposals submitted to other programs both within the Social, Behavioral, and Economic Sciences Directorate and across other directorates. Proposals may involve clinical populations, animals, brain imaging, or computational modeling, or factors such as emotion and sleep, only if the work has direct impact on our understanding of basic processes underlying human perception, action, or cognition.

Funding Website: 

NSF_PAC

Keywords: Audiology, Balance (physical), Cognitive Development or Processes, Ears & Hearing, Human Learning and Memory, Sensory Integration Disorders, Sensory Physiology,  Sensory System, Vision

*Anticipated* Application Due Date (s): June 18, 2022

Sponsoring Agency: Bryon Riesch Paralysis Foundation

Amount Available:  $2000 - $4000

Abstract: Priority going to direct spinal cord injuries and diseases resulting in paralysis such as spinal tumors, strokes or aneurysms affecting the spinal cord, or spina bifida. Other diseases and disorders that would be considered include MS, traumatic brain injuries, Parkinson's and cerebral palsy.

Eligibility: Individuals: Undergraduate Student Persons with Disabilities only

Funding Website: 
BRPF Scholarship 

Keywords: Cerebral Palsy, Higher Education, Multiple Sclerosis, Paralysis, Parkinsons Disease, Spinal Cord Diseases, Spinal Cord Injury, Undergraduate Education

*Anticipated* Annual Application Due Date (s): June 24, 2024 

Sponsoring Agency:  American College of Neuropsychopharmacology (ACNP)

Abstract: The American College of Neuropsychopharmacology (ACNP) presents NINE awards during its annual meeting.  Awards consists of a monetary award and a plaque to be given during the Annual Meeting. The award winner must attend the Annual Meeting. See website for more information.  

• Paul Hoch Distinguished Service Award - The ACNP presents this award when a member has made unusually significant contributions to the College. The emphasis of this award is on service to the College;not for teaching, clinical, or research accomplishment.
  

• Julius Axelrod Mentorship Award - The ACNP presents this award to an ACNP member who has made an outstanding contribution to neuropsychopharmacology by mentoring and developing young scientists into leaders in the field.
  

• Eva King Killam Research Award - The ACNP presents this award to an early career researcher on the basis of outstanding translational research contributions to neuropsychopharmacology. The nominee's research should contribute to translating between basic science and human investigations. The selection of the awardee is based on the quality of the contribution and its impact in advancing neuropsychopharmacology.
  

• ACNP Media Award- The ACNP Media Award was established to recognize major contributions to the education of the public about mental illness and substance abuse research and the positive impact of research on treatment.
  

• Daniel H. Efron Research Award - The ACNP presents this award to an individual on the basis of outstanding basic research contributions to neuropsychopharmacology. The selection of the awardee is based on the quality of the contributions and their impact in advancing neuropsychopharmacology.
  

Funding Website: 
ACNP Honorific Awards

Application Due Date (s): Ongoing - quarterly: March, June, September, and December.

Sponsoring Agency:  Project Athena Foundation

Amount Available: see website:

Abstract: The Project Athena Foundation is a 501c3 non-profit foundation dedicated to helping survivors of medical or other traumatic setbacks achieve their adventurous dreams. At Project Athena, we provide travel expenses, coaching, equipment, and most importantly, the encouragement and inspiration needed to help these strong, amazing women make that life-affirming transition from Survivor to Athlete. We currently offer four yearly adventures that provide mental and physical challenges in a non-competitive environment. At Project Athena, we believe it’s all about teamwork and being a part of the family. Apply today to join us as an Athena, if you are a survivor of a medical setback, OR register for an event as a Fundraising God or Goddess to show your support for a great cause!

Applicant Type:  Individuals: Early Career and Emerging in Field Individuals: Graduate Student or Pre-doc Individuals: Mid-Career to Established in Field Individuals: Undergraduate Student

Funding Website: 
Athena Grant 

Keywords: Cancer or Carcinogenesis, Chronic Illnesses, Exercise, Posttraumatic Stress Disorder, Trauma and Emergency Surgery, Traumatic Brain Injury, Traumatology, Accidents & Injury, Womens Health